Hrt Financial »

Context Therapeutics shares owned by Hrt Financial

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by Hrt Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $275k 105k 2.62
2021-12-31 $27k 10k 2.66

More positions owned by Hrt Financial

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Put
Microsoft Corp Call
Sandisk Corp (SNDK)
Nvidia Corporation Call
Nvidia Corporation Put
Apple Call
Amazon Call
Wal-Mart Stores (WMT)
Apple (AAPL)
Meta Platforms Call
Marvell Technology (MRVL)
Ishares Tr Put

View all positions for Hrt Financial

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Nextech Invest
Deep Track Capital
Soleus Capital Management
Octagon Capital Advisors
Avidity Partners Management
Franklin Resources
Vanguard Group
Vanguard Capital Management
TCG Crossover Management
Marshall Wace
Dr. Jeffrey R. Jay, M.D.
Millennium Management
Sio Capital Management

View all funds holding Context Therapeutics